A Prospective, Randomized, Double-Blinded Study of the Effect of Intravenous Ondansetron on the Effective Dose in 50% of Subjects of Prophylactic Phenylephrine Infusions for Preventing Spinal Anesthesia-Induced Hypotension During Cesarean Delivery

Ondansetron has been shown to reduce the incidence of hypotension and vasopressor requirement during spinal anesthesia for obstetric and nonobstetric surgery. However, the magnitude of this effect has not been fully quantified. In this parallel-group, randomized, double-blinded study, we determined...

Full description

Saved in:
Bibliographic Details
Published in:Anesthesia and analgesia Vol. 131; no. 2; p. 564
Main Authors: Xiao, Fei, Wei, Changna, Chang, Xiangyang, Zhang, Yinfa, Xue, Lili, Shen, Huaxiang, Ngan Kee, Warwick D, Chen, Xinzhong
Format: Journal Article
Language:English
Published: United States 01.08.2020
Subjects:
ISSN:1526-7598, 1526-7598
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Ondansetron has been shown to reduce the incidence of hypotension and vasopressor requirement during spinal anesthesia for obstetric and nonobstetric surgery. However, the magnitude of this effect has not been fully quantified. In this parallel-group, randomized, double-blinded study, we determined the effective dose in 50% of subjects (ED50) of a prophylactic phenylephrine infusion for preventing hypotension in patients who received a single dose of intravenous ondansetron 4 mg or saline control before combined spinal-epidural anesthesia for elective cesarean delivery. ED50 values obtained were compared to estimate the effect of ondansetron versus placebo on vasopressor requirement. Sixty parturients were randomly assigned to receive ondansetron (group O) or saline control (group C) 10 minutes before positioning for induction of spinal anesthesia. A prophylactic phenylephrine infusion was used to prevent hypotension. The first patient in each group received a phenylephrine infusion at the rate of 0.5 µg/kg/min. The infusion rate for each subsequent patient was varied with increments or decrements of 0.05 µg/kg/min based on the response of the previous patient, and the effective dose of the phenylephrine infusion for preventing hypotension in 50% of patients (ED50) was calculated for each group and compared using up-down sequential analysis. Probit regression was applied as a backup and sensitivity analysis was used to compare ED50 values for phenylephrine between groups by comparing calculated relative mean potency. The ED50 (mean [95% confidence interval (CI)]) of the rate of phenylephrine infusion was lower in group O (0.24 µg/kg/min [0.10-0.38 µg/kg/min]) compared with group C (0.32 µg/kg/min [0.14-0.47 µg/kg/min]) (P < .001). The total consumption of phenylephrine (mean ± standard deviation [SD]) until delivery was lower in group O (316.5 ± 25.9 µg) than in group C (387.7 ± 14.7 µg, P = .02). The estimate of relative median potency for phenylephrine for group O versus group C was 0.74 (95% CI, 0.37-0.95). Under the conditions of this study, intravenous ondansetron 4 mg reduced the ED50 of a prophylactic phenylephrine infusion by approximately 26% in patients undergoing cesarean delivery under combined spinal-epidural anesthesia.
AbstractList Ondansetron has been shown to reduce the incidence of hypotension and vasopressor requirement during spinal anesthesia for obstetric and nonobstetric surgery. However, the magnitude of this effect has not been fully quantified. In this parallel-group, randomized, double-blinded study, we determined the effective dose in 50% of subjects (ED50) of a prophylactic phenylephrine infusion for preventing hypotension in patients who received a single dose of intravenous ondansetron 4 mg or saline control before combined spinal-epidural anesthesia for elective cesarean delivery. ED50 values obtained were compared to estimate the effect of ondansetron versus placebo on vasopressor requirement.BACKGROUNDOndansetron has been shown to reduce the incidence of hypotension and vasopressor requirement during spinal anesthesia for obstetric and nonobstetric surgery. However, the magnitude of this effect has not been fully quantified. In this parallel-group, randomized, double-blinded study, we determined the effective dose in 50% of subjects (ED50) of a prophylactic phenylephrine infusion for preventing hypotension in patients who received a single dose of intravenous ondansetron 4 mg or saline control before combined spinal-epidural anesthesia for elective cesarean delivery. ED50 values obtained were compared to estimate the effect of ondansetron versus placebo on vasopressor requirement.Sixty parturients were randomly assigned to receive ondansetron (group O) or saline control (group C) 10 minutes before positioning for induction of spinal anesthesia. A prophylactic phenylephrine infusion was used to prevent hypotension. The first patient in each group received a phenylephrine infusion at the rate of 0.5 µg/kg/min. The infusion rate for each subsequent patient was varied with increments or decrements of 0.05 µg/kg/min based on the response of the previous patient, and the effective dose of the phenylephrine infusion for preventing hypotension in 50% of patients (ED50) was calculated for each group and compared using up-down sequential analysis. Probit regression was applied as a backup and sensitivity analysis was used to compare ED50 values for phenylephrine between groups by comparing calculated relative mean potency.METHODSSixty parturients were randomly assigned to receive ondansetron (group O) or saline control (group C) 10 minutes before positioning for induction of spinal anesthesia. A prophylactic phenylephrine infusion was used to prevent hypotension. The first patient in each group received a phenylephrine infusion at the rate of 0.5 µg/kg/min. The infusion rate for each subsequent patient was varied with increments or decrements of 0.05 µg/kg/min based on the response of the previous patient, and the effective dose of the phenylephrine infusion for preventing hypotension in 50% of patients (ED50) was calculated for each group and compared using up-down sequential analysis. Probit regression was applied as a backup and sensitivity analysis was used to compare ED50 values for phenylephrine between groups by comparing calculated relative mean potency.The ED50 (mean [95% confidence interval (CI)]) of the rate of phenylephrine infusion was lower in group O (0.24 µg/kg/min [0.10-0.38 µg/kg/min]) compared with group C (0.32 µg/kg/min [0.14-0.47 µg/kg/min]) (P < .001). The total consumption of phenylephrine (mean ± standard deviation [SD]) until delivery was lower in group O (316.5 ± 25.9 µg) than in group C (387.7 ± 14.7 µg, P = .02). The estimate of relative median potency for phenylephrine for group O versus group C was 0.74 (95% CI, 0.37-0.95).RESULTSThe ED50 (mean [95% confidence interval (CI)]) of the rate of phenylephrine infusion was lower in group O (0.24 µg/kg/min [0.10-0.38 µg/kg/min]) compared with group C (0.32 µg/kg/min [0.14-0.47 µg/kg/min]) (P < .001). The total consumption of phenylephrine (mean ± standard deviation [SD]) until delivery was lower in group O (316.5 ± 25.9 µg) than in group C (387.7 ± 14.7 µg, P = .02). The estimate of relative median potency for phenylephrine for group O versus group C was 0.74 (95% CI, 0.37-0.95).Under the conditions of this study, intravenous ondansetron 4 mg reduced the ED50 of a prophylactic phenylephrine infusion by approximately 26% in patients undergoing cesarean delivery under combined spinal-epidural anesthesia.CONCLUSIONSUnder the conditions of this study, intravenous ondansetron 4 mg reduced the ED50 of a prophylactic phenylephrine infusion by approximately 26% in patients undergoing cesarean delivery under combined spinal-epidural anesthesia.
Ondansetron has been shown to reduce the incidence of hypotension and vasopressor requirement during spinal anesthesia for obstetric and nonobstetric surgery. However, the magnitude of this effect has not been fully quantified. In this parallel-group, randomized, double-blinded study, we determined the effective dose in 50% of subjects (ED50) of a prophylactic phenylephrine infusion for preventing hypotension in patients who received a single dose of intravenous ondansetron 4 mg or saline control before combined spinal-epidural anesthesia for elective cesarean delivery. ED50 values obtained were compared to estimate the effect of ondansetron versus placebo on vasopressor requirement. Sixty parturients were randomly assigned to receive ondansetron (group O) or saline control (group C) 10 minutes before positioning for induction of spinal anesthesia. A prophylactic phenylephrine infusion was used to prevent hypotension. The first patient in each group received a phenylephrine infusion at the rate of 0.5 µg/kg/min. The infusion rate for each subsequent patient was varied with increments or decrements of 0.05 µg/kg/min based on the response of the previous patient, and the effective dose of the phenylephrine infusion for preventing hypotension in 50% of patients (ED50) was calculated for each group and compared using up-down sequential analysis. Probit regression was applied as a backup and sensitivity analysis was used to compare ED50 values for phenylephrine between groups by comparing calculated relative mean potency. The ED50 (mean [95% confidence interval (CI)]) of the rate of phenylephrine infusion was lower in group O (0.24 µg/kg/min [0.10-0.38 µg/kg/min]) compared with group C (0.32 µg/kg/min [0.14-0.47 µg/kg/min]) (P < .001). The total consumption of phenylephrine (mean ± standard deviation [SD]) until delivery was lower in group O (316.5 ± 25.9 µg) than in group C (387.7 ± 14.7 µg, P = .02). The estimate of relative median potency for phenylephrine for group O versus group C was 0.74 (95% CI, 0.37-0.95). Under the conditions of this study, intravenous ondansetron 4 mg reduced the ED50 of a prophylactic phenylephrine infusion by approximately 26% in patients undergoing cesarean delivery under combined spinal-epidural anesthesia.
Author Chang, Xiangyang
Ngan Kee, Warwick D
Xiao, Fei
Xue, Lili
Wei, Changna
Shen, Huaxiang
Chen, Xinzhong
Zhang, Yinfa
Author_xml – sequence: 1
  givenname: Fei
  surname: Xiao
  fullname: Xiao, Fei
  organization: From the Department of Anesthesia, Jiaxing University Affiliated Women and Children Hospital, Jiaxing City, China
– sequence: 2
  givenname: Changna
  surname: Wei
  fullname: Wei, Changna
  organization: Department of Anesthesia, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China
– sequence: 3
  givenname: Xiangyang
  surname: Chang
  fullname: Chang, Xiangyang
  organization: From the Department of Anesthesia, Jiaxing University Affiliated Women and Children Hospital, Jiaxing City, China
– sequence: 4
  givenname: Yinfa
  surname: Zhang
  fullname: Zhang, Yinfa
  organization: From the Department of Anesthesia, Jiaxing University Affiliated Women and Children Hospital, Jiaxing City, China
– sequence: 5
  givenname: Lili
  surname: Xue
  fullname: Xue, Lili
  organization: Department of Obstetrics, Jiaxing University Affiliated Women and Children Hospital, Jiaxing City, China
– sequence: 6
  givenname: Huaxiang
  surname: Shen
  fullname: Shen, Huaxiang
  organization: Department of Obstetrics, Jiaxing University Affiliated Women and Children Hospital, Jiaxing City, China
– sequence: 7
  givenname: Warwick D
  surname: Ngan Kee
  fullname: Ngan Kee, Warwick D
  organization: Department of Anesthesiology, Sidra Medicine, Doha, Qatar
– sequence: 8
  givenname: Xinzhong
  surname: Chen
  fullname: Chen, Xinzhong
  organization: Department of Anesthesia, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31725021$$D View this record in MEDLINE/PubMed
BookMark eNpNUU1r3DAQFSUlH9v8g1J0KfQQp9aH7d3jZrNNFkITurkvsjTuKnhHrmQH3D_ea8c0oREDmkHvvXmaOWNHGBAY-yjySyGF-rr8vr7M3xxdKP2OnYpClllVLOZHb_ITdpbSE4FEPi-P2YkSlSxyKU7ZnyV_iCF1YHv_DBf8h0EXDv43uAt-HYa6heyq9ejA8W0_uJGHhvd74OumIcpUbbCP5hkwDInfozOYoI8BOcV_IGmTXALukRf554m3HeoneklTTha6_dgaAlr-sAccW-j20SOQfDMkHzDxJkQCArXqPf7k286jafkSIVGf5E22QTdYMno7dqEHnFj8eogTeAXJRDBUQ0te4viBvW9Mm-D85Z6xx2_rx9Vtdnd_s1kt7zKrc6FpeNo4UwpRWGOFVuBKpawqFou8rJ0FKG1tFxV9sRHWOiPFHGqpVWUq4jVyxr78k-1i-DWQ093BJwttaxBoYDuphC4qLWkfM_bpBTrUB3C7LvqDiePudVfyL6Ornys
CitedBy_id crossref_primary_10_1186_s12884_024_06937_7
crossref_primary_10_2147_LRA_S240753
crossref_primary_10_3390_ph15121588
crossref_primary_10_1097_JS9_0000000000001255
crossref_primary_10_3389_fphar_2022_942005
crossref_primary_10_1016_j_jclinane_2020_110115
crossref_primary_10_1371_journal_pone_0305913
crossref_primary_10_2147_DDDT_S307478
crossref_primary_10_1016_j_jopan_2024_07_023
crossref_primary_10_1007_s00404_022_06523_2
crossref_primary_10_1016_j_jopan_2021_05_007
crossref_primary_10_2147_DDDT_S452983
crossref_primary_10_2147_DDDT_S257880
crossref_primary_10_7759_cureus_65073
crossref_primary_10_1080_17512433_2021_1929924
crossref_primary_10_2147_DDDT_S473662
crossref_primary_10_36290_aim_2020_062
crossref_primary_10_1097_JS9_0000000000000920
crossref_primary_10_3389_fmed_2021_669264
crossref_primary_10_1213_ANE_0000000000005518
crossref_primary_10_4103_ija_ija_870_21
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1213/ANE.0000000000004534
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
EISSN 1526-7598
ExternalDocumentID 31725021
Genre Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.-D
.55
.GJ
.XZ
.Z2
01R
026
0R~
1CY
1J1
23M
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAAXR
AAFWJ
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AAQQT
AARTV
AASCR
AASOK
AAUEB
AAWTL
AAXQO
ABASU
ABBUW
ABDIG
ABJNI
ABKPX
ABOCM
ABPPZ
ABPXF
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACCJW
ACDDN
ACDOF
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACLED
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFBFQ
AFDTB
AFEXH
AFFNX
AFMBP
AFMFG
AFNMH
AFSOK
AFUWQ
AGINI
AHOMT
AHQNM
AHQVU
AHRYX
AHVBC
AHXIK
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJRGT
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BAWUL
BOYCO
BQLVK
BS7
C1A
C45
CGR
CS3
CUY
CVF
DIWNM
DUNZO
E.X
E3Z
EBS
ECM
EEVPB
EIF
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FRP
FW0
GNXGY
GQDEL
GX1
H0~
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
L-C
L7B
M18
MZP
N4W
N9A
NPM
N~7
N~B
N~M
O9-
OAG
OAH
OB4
OCUKA
ODA
ODMTH
OHYEH
OK1
OL1
OLG
OLH
OLL
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PONUX
R58
RIG
RLZ
S4R
S4S
TEORI
TR2
TSPGW
V2I
VVN
W3M
W8F
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YOC
YQJ
ZFV
ZGI
ZXP
ZZMQN
7X8
ADKSD
ADSXY
ID FETCH-LOGICAL-c4014-754ada6115cac143ed633c359906bdcee6cbc97fecf1ccda218eb2437a7adaf2
IEDL.DBID 7X8
ISICitedReferencesCount 23
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=00000539-202008000-00034&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1526-7598
IngestDate Mon Sep 08 07:20:36 EDT 2025
Mon Jul 21 05:40:53 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4014-754ada6115cac143ed633c359906bdcee6cbc97fecf1ccda218eb2437a7adaf2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
PMID 31725021
PQID 2314574217
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2314574217
pubmed_primary_31725021
PublicationCentury 2000
PublicationDate 2020-08-00
20200801
PublicationDateYYYYMMDD 2020-08-01
PublicationDate_xml – month: 08
  year: 2020
  text: 2020-08-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Anesthesia and analgesia
PublicationTitleAlternate Anesth Analg
PublicationYear 2020
SSID ssj0001086
Score 2.4584732
Snippet Ondansetron has been shown to reduce the incidence of hypotension and vasopressor requirement during spinal anesthesia for obstetric and nonobstetric surgery....
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 564
SubjectTerms Adult
Anesthesia, Spinal - adverse effects
Antiemetics - administration & dosage
Antiemetics - blood
Cesarean Section - methods
Dose-Response Relationship, Drug
Double-Blind Method
Drug Synergism
Female
Humans
Hypotension - blood
Hypotension - chemically induced
Hypotension - prevention & control
Infusions, Intravenous
Ondansetron - administration & dosage
Ondansetron - blood
Phenylephrine - administration & dosage
Phenylephrine - blood
Pre-Exposure Prophylaxis - methods
Pregnancy
Prospective Studies
Treatment Outcome
Vasoconstrictor Agents - administration & dosage
Vasoconstrictor Agents - blood
Title A Prospective, Randomized, Double-Blinded Study of the Effect of Intravenous Ondansetron on the Effective Dose in 50% of Subjects of Prophylactic Phenylephrine Infusions for Preventing Spinal Anesthesia-Induced Hypotension During Cesarean Delivery
URI https://www.ncbi.nlm.nih.gov/pubmed/31725021
https://www.proquest.com/docview/2314574217
Volume 131
WOSCitedRecordID wos00000539-202008000-00034&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELag5cCFh3gVChokuDXq5un1qdqWVuXAsoIe9rbyKxApOEsDlZY_zpVvnKz2hIREFEWJFDtOPJn5PB5_I8QbntxxqeFpdcC3Qk2KhM1CAnlyhYHJ1MrEZBNyPp8ul2oxOtz6MaxyqxOjonadZR_5MXBIUWIcl8qT9feEs0bx7OqYQuO22M8BZViq5XLHFs5ZhCJfalYlslTTcelclubHs_n5QF04bkXJqZP_BjKjsbm4_7_NfCDujTCTZoNcPBS3fHgkfs9ocd1t11Ye0ScdXPet-eXdEQFIm9Ynpy3TJzri8MINdTUBH9LAcMxX79kVfBNpXekjBvOh9-xKJ-y7G1E3qus9NYHKyVsuB_XE_p6ez9EEdG0bF2fR4qsPm9ZDooB2UX39k713PQFK05ZdKnyhz-smvg70Mp7TNzrhlCMWDb3crLsYhI8mvItLLunM9xpQGNe-5aiTzWNxdXF-dXaZjIkfEovhXoG-KrTTFcCq1RaAzrsqz21ewnJWxsGsV9ZYJfFKdWqt04Ap3jCzopYoV2dPxF7ogn8mSKsy81pKNa11YXKjJtJBrSobafzl5EC83nbjCv8VT5bo4PERV7uOPBBPB1lYrQcCkBUwF5Bjlj7_h9IvxN2Mh-gxZvBQ7NfQKv6luGNvfjT99asosDjOFx_-ANH6-XA
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Prospective%2C+Randomized%2C+Double-Blinded+Study+of+the+Effect+of+Intravenous+Ondansetron+on+the+Effective+Dose+in+50%25+of+Subjects+of+Prophylactic+Phenylephrine+Infusions+for+Preventing+Spinal+Anesthesia-Induced+Hypotension+During+Cesarean+Delivery&rft.jtitle=Anesthesia+and+analgesia&rft.au=Xiao%2C+Fei&rft.au=Wei%2C+Changna&rft.au=Chang%2C+Xiangyang&rft.au=Zhang%2C+Yinfa&rft.date=2020-08-01&rft.eissn=1526-7598&rft.volume=131&rft.issue=2&rft.spage=564&rft_id=info:doi/10.1213%2FANE.0000000000004534&rft_id=info%3Apmid%2F31725021&rft_id=info%3Apmid%2F31725021&rft.externalDocID=31725021
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1526-7598&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1526-7598&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1526-7598&client=summon